Ads
related to: Pfizer
Search results
The Savvy Investor’s Cheat Sheet: 3 Deep Value Picks for May 2024
InvestorPlace via Yahoo Finance· 6 days agoWith many market strategists turning slightly bullish amid this bull market, investors may wonder if...
Pfizer rolls out another cost-cutting program, sets $1.5 billion target by 2027
Reuters· 6 days ago, opens new tab on Wednesday launched a new multi-year program to reduce its expenses by about $1.5...
Pfizer plans to cut costs by $1.5 billion as demand for COVID vaccine dwindles
Quartz· 7 days agoPharma giant Pfizer announced Wednesday another cost-cutting initiative as the company struggles...
1 No-Brainer Dividend Stock Yielding More Than 5% to Buy and Hold Forever | The Motley Fool
The Motley Fool· 4 days agoWhen looking to invest in dividend stocks, chasing high yields isn't always an advisable strategy....
Is Pfizer Finally Seeing Light at the End of the Tunnel?
TheStreet.com· 6 days agoPharmaceutical giant Pfizer (PFE) has been a weak performer in the stock market. The shares are...
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend...
Benzinga· 1 day agoPfizer Inc. PFE Dividend Yield: 5.82% Morgan Stanley analyst Terence Flynnmaintained an Equal-Weight...
Jim Cramer: Celestica Makes A 'Comeback,' Sell This Movie Theater Stock, - Moderna (NASDAQ:MRNA)
Benzinga· 1 day agoJim Cramer called Celestica Inc. "terrific" after the Toronto-based company reported...
Exact Sciences (EXAS) Witnesses Rising Expenses, Competition
Zacks via Yahoo Finance· 4 hours agoOn a positive note, the company is confident about capturing at least 40% of the U.S. colorectal...
Pfizer (PFE) Recently Broke Out Above the 200-Day Moving Average
Zacks· 7 days agoFree Report) is looking like an interesting pick, as it just reached a key level of support. PFE recently overtook the 200-day moving average, and this suggests a long-term bullish trend. The ...
How Much Will Pfizer Pay Out in Dividends This Year? | The Motley Fool
The Motley Fool· 3 days agoA vaccine and an antiviral treatment for COVID-19 made Pfizer (PFE 0.66%) a household name in recent years, but this isn't all the company sells. There are dozens of innovative ...